Altium Capital Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-111,000
| Closed | -$2.62M | – | 89 |
|
|
2023
Q4 | $2.62M | Sell |
111,000
-689,000
| -86% | -$16.3M | 1.78% | 18 |
|
|
2023
Q3 | $11.9M | Buy |
800,000
+131,298
| +20% | +$1.96M | 6.22% | 1 |
|
|
2023
Q2 | $7.32M | Buy |
668,702
+48,702
| +8% | +$533K | 5.54% | 6 |
|
|
2023
Q1 | $5.41M | Sell |
620,000
-405,000
| -40% | -$3.53M | 3% | 6 |
|
|
2022
Q4 | $6.43M | Sell |
1,025,000
-725,000
| -41% | -$4.55M | 3.27% | 7 |
|
|
2022
Q3 | $6.13M | Hold |
1,750,000
| – | – | 2.25% | 6 |
|
|
2022
Q2 | $5.16M | Hold |
1,750,000
| – | – | 2.07% | 10 |
|
|
2022
Q1 | $5.44M | Hold |
1,750,000
| – | – | 1.82% | 15 |
|
|
2021
Q4 | $5.92M | Buy |
+1,750,000
| New | +$5.92M | 1.63% | 14 |
|